Mac Fund is an institutional investor (Conventional VCs) founded in 1970 and headquartered in Seoul, South Korea. MAC Fund is a late stage venture capital investment company. Invests in geographies like Israel, South Korea and Asia. Typically invests in life sciences and tech companies operating in sectors like CleanTech, SaaS, Medical Devices and Biopharma. Top investments include EndoChoice, Ornim Medical, eyeSight. Notable portfolio companies: EndoChoice, Ornim Medical, eyeSight. The firm is no longer active (deadpooled).

Stage

pre-seed, seed, Series A, pre-seed, seed, Series A

Check size

$500K-$4M

HQ

Seoul, South Korea

Founded

1970

Website

http://mac-vc.com

LinkedIn

https://linkedin.com/company/genzero

Twitter

https://twitter.com/genzerot

What they look for

visionary founders with real products and early traction, domain expertise, cultural fluency, preference for diverse founders (BIPOC, underrepresented minorities), US primary with global opportunities especially Africa/Asia

Preparing to pitch Mac Fund?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.